Neisseria meningitidis, the cause of epidemic meningitis and acute lethal sepsis, synthesizes surplus lipopolysaccharides (LPSs) during growth, which are released as outer membrane vesicles (OMV) or `blebs'. Meningococcal disease severity is related to plasma LPS levels. We have compared the biological activities of native outer membrane vesicles (nOMV) to those of purified Nm-LPS (Nm-LPS) and LPS-depleted OMV (dOMV) prepared from N. meningitidis. The LPS content of nOMV was determined spectrophotometrically by quantifying KDO and by silver-stained SDS-PAGE gels. The morphology of the preparations was studied by transmission electron microscopy. The Limulus amoebocyte lysate (LAL) assay was used to quantify LPS in the plasma solutions. The preparations were diluted in endotoxin-free heparin plasma to equal amounts of LPS (w/w) in the range 50—5000 pg/ml. The biological reactivity was tested by: (i) a monocyte target-assay (monocyte purity ≥ 96%); and (ii) a whole blood model, measuring the secretion of TNF-α and IL-6 induction of procoagulant activity in monocytes (PCA). In both models, nOMV induced dose-dependent cell responses (TNF-α, IL-6, PCA) similar to purified Nm-LPS, whereas dOMV induced minimal responses. However, LAL activity was significantly higher for nOMV than for purified Nm-LPS and dOMV. The cellular responses of purified Nm-LPS and nOMV were reduced (>95%) by a specific anti-CD 14-antibody.
References
1.
van Deuren M. , Brandtzaeg P., Der Meer JWUpdate on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev2000; 13: 144—166.
2.
Brandtzaeg P. , Kierulf P., Gaustad P. et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis1989; 159: 195—204.
3.
Brandtzaeg P. , Bryn K., Kierulf P. et al. Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J Clin Invest1992 ; 89: 816—823.
4.
Brandtzaeg P, vstebø R, Kierulf P. Bacteremia and compartmentalization of LPS in meningococcal disease. In: Levin J , Alving CR, Munford RS, Redl H. (eds) Bacterial Endotoxins, Lipopolysaccharides from Gene to Therapy . New York: Wiley-Liss, 1995; 219—233.
5.
Devoe IW, Gilchrist JERelease of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis. J Exp Med1973; 138: 1156—1167.
6.
Andersen BM, Skjorten F., Solberg O.Electron microscopical study of Neisseria meningitidis releasing various amounts of free endotoxin. Acta Pathol Microbiol Scand [B] 1979; 87B: 109—115.
7.
Stephens DS, Edwards KM, Morris F., McGee ZAPili and outer membrane appendages on Neisseria meningitidis in the cerebrospinal fluid of an infant. J Infect Dis1982; 146: 568.
8.
Beveridge TJStructures of Gram-negative cell walls and their derived membrane vesicles. J Bacteriol1999 ; 181: 4725—4733.
9.
Rietschel ET , Schletter J., Weidemann B. et al. Lipopolysaccharide and peptidoglycan: CD14-dependent bacterial inducers of inflammation. Microb Drug Resist1998; 4: 37—44.
10.
Lorenzen DR , Düx F., Wölk U., Tsirpouchtsidis A., Haas G., Meyer TFImmunoglobulin A1 protease, an exoenzyme of pathogenic Neisseriae, is a potent inducer of proinflammatory cytokines. J Exp Med1999; 190: 1049—1058.
11.
Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JCCD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science1990; 249: 1431—1433.
12.
Schumann RR , Leong SR, Flaggs GW et al. Structure and function of lipopolysaccharide binding protein. Science1990; 249: 1429—1431.
13.
Poltorak A. , He X., Smirnova I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science1998; 282: 2085—2088.
14.
Beutler B.Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol2000; 12: 20—26.
15.
Brandtzaeg P.Pathogenesis of meningococcal infections. In: Cartwright K. (ed) Meningococcal Disease. Chichester: Wiley, 1995; 71—114.
16.
Brandtzaeg P.Systemic meningococcal disease: clinical pictures and pathophysiological background. Rev Med Microbiol1996; 7: 63—72.
17.
Fredriksen JH, Rosenqvist E., Wedege E. et al. Production, characterization and control of MenB-vaccine `Folkehelsa': an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann1991; 14: 67—79.
18.
Tsai CM, Frasch CE, Rivera E., Hochstein HDMeasurements of lipopolysaccharide (endotoxin) in meningococcal protein and polysaccharide preparations for vaccine usage. J Biol Stand1989; 17: 249—258.
19.
Caugant DA, Froholm LO, Bovre K. et al. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci USA1986; 83: 4927—4931.
20.
Abdillahi H. , Poolman JTTyping of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA. J Med Microbiol1988; 26: 177—180.
21.
Andersen SR , Bryn K., Thorseng K., Jantzen E.Heterogeneity of lipopolysaccharides of Neisseria meningitidis revealed by thin-layer chromatography combined with monoclonal antibodies. J Microbiol Methods1996; 25: 187—194.
22.
Frasch CE, Mocca LFHeat-modifiable outer membrane proteins of Neisseria meningitidis and their organization within the membrane. J Bacteriol1978; 136: 1127—1134.
23.
Harthug S., Rosenqvist E., Hoiby EA, Gedde-Dahl TW, Froholm LOAntibody response in group B meningococcal disease determined by enzyme-linked immunosorbent assay with serotype 15 outer membrane antigen. J Clin Microbiol1986; 24: 947—953.
24.
Osnes LT, Westvik AB, Kierulf P.Procoagulant and profibrinolytic activities of cryopreserved human monocytes . Thromb Res1994; 76: 373—383.
25.
Karkhanis YD , Zeltner JY, Jackson JJ, Carlo DJA new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria. Anal Biochem1978; 85: 595—601.
26.
Jungi TWA turbidimetric assay in an ELISA reader for the determination of mononuclear phagocyte procoagulant activity. J Immunol Methods1990; 133: 21—29.
27.
Osnes L., Westvik ÅB, vstebø R., Joø GB, Okkenhaug C., Kierulf P.Lipopolysaccharide activation of human monocytes mediated by CD14, results in coordinated synthesis of tissue factor, TNF-α and IL-6. J Endotoxin Res1995; 2: 27—35.
28.
Brandtzaeg P. , vstebø R., Kierulf P.Quantitative detection of bacterial lipopolysaccharides in clinical specimens. In: Pollard AJ, Maiden MCJ. (eds) Meningococcal Disease Protocols . Totowa, NJ: Humana Press, 2001; In press.
29.
Leturcq DJ, Moriarty AM, Talbott G., Winn RK, Martin TR, Ulevitch RJAntibodies against CD14 protect primates from endotoxin-induced shock . J Clin Invest1996; 98: 1533—1538.
30.
Hazelzet JA , Stubenitsky R., Petrov AB et al. Cardiovascular aspects of experimental meningococcal sepsis in young and older awake piglets: age-related differences . Shock1999; 12: 145—154.
31.
Mustafa MM, Ramilo O., Syrogiannopoulos GA, Olsen KD, McCrackenJr. GH, Hansen EJ. Induction of meningeal inflammation by outer membrane vesicles of Hemophilus influenzae type b. J Infect Dis1989; 159: 917—922.
32.
Zhou L., Srisatjaluk R., Justus DE, Doyle RJOn the origin of membrane vesicles in Gram-negative bacteria. FEMS Microbiol Lett1998; 163: 223—228.
33.
Kadurugamuwa JL, Beveridge TJVirulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J Bacteriol1995; 177: 3998—4008.
